NCT04601584 2024-03-06GNR-084 Safety and Pharmacological Characteristics in Refractory or Relapse B-cell Precursor ALLAO GENERIUMPhase 1/2 Unknown36 enrolled
NCT00324597 2013-09-17AMG 706 and Gemcitabine in Treating Patients With Advanced Solid Tumors or LymphomaNational Cancer Institute (NCI)Phase 1 Unknown18 enrolled